Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.
Transplantation|June 30, 2023
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative ConditioningAniko Sijs-Szabo, Avinash G Dinmohamed, Jurjen Versluis, et al.
Hemasphere|December 12, 2024
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trialAnnoek E C Broers, Ellen Meijer, Bronno van der Holt, et al.
Frontiers in Immunology|January 7, 2022
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
Bone Marrow Transplantation|November 9, 2019
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemiaMauricette Michallet, Peter Dreger, Mohamad Sobh, et al.
Frontiers in Immunology|February 5, 2021
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
Leukemia|December 22, 2018
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaJohannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, et al.
Bone Marrow Transplantation|December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMTGwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Pageof 6